|
US4164559A
(en)
|
1977-09-21 |
1979-08-14 |
Cornell Research Foundation, Inc. |
Collagen drug delivery device
|
|
US4474752A
(en)
|
1983-05-16 |
1984-10-02 |
Merck & Co., Inc. |
Drug delivery system utilizing thermosetting gels
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
GB9414139D0
(en)
|
1994-07-13 |
1994-08-31 |
Smithkline Beecham Plc |
Novel compounds
|
|
ES2131463B1
(es)
|
1997-04-08 |
2000-03-01 |
Lilly Sa |
Derivados de ciclopropilglicina con propiedades farmaceuticas.
|
|
DE19746287A1
(de)
*
|
1997-10-20 |
1999-04-22 |
Hoechst Marion Roussel De Gmbh |
Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
US6440102B1
(en)
|
1998-07-23 |
2002-08-27 |
Durect Corporation |
Fluid transfer and diagnostic system for treating the inner ear
|
|
DE19853299C2
(de)
|
1998-11-19 |
2003-04-03 |
Thomas Lenarz |
Katheter zur Applikation von Medikamenten in Flüssigkeitsräumen des menschlichen Innenohrs
|
|
US6120484A
(en)
|
1999-02-17 |
2000-09-19 |
Silverstein; Herbert |
Otological implant for delivery of medicament and method of using same
|
|
DE60026297T2
(de)
|
1999-05-21 |
2006-11-02 |
Bristol-Myers Squibb Co. |
Pyrrolotriazin kinasehemmer
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
US6967023B1
(en)
|
2000-01-10 |
2005-11-22 |
Foamix, Ltd. |
Pharmaceutical and cosmetic carrier or composition for topical application
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
WO2001083481A1
(en)
|
2000-04-27 |
2001-11-08 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
|
US7064215B2
(en)
|
2001-07-03 |
2006-06-20 |
Chiron Corporation |
Indazole benzimidazole compounds
|
|
US6648873B2
(en)
|
2001-09-21 |
2003-11-18 |
Durect Corp. |
Aural catheter system including anchor balloon and balloon inflation device
|
|
JP5039268B2
(ja)
|
2001-10-26 |
2012-10-03 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
ベンゾイミダゾールおよび類縁体および蛋白キナーゼ阻害剤としてのその使用
|
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
|
CA2464333C
(en)
|
2001-10-26 |
2011-07-26 |
University Of Connecticut |
Heteroindanes: a new class of potent cannabimimetic ligands
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
BR0307796A
(pt)
|
2002-02-19 |
2004-12-21 |
Pharmacia Corp |
Derivados tricìclicos de pirazol para o tratamento de inflamação
|
|
US20040127492A1
(en)
|
2002-02-19 |
2004-07-01 |
Pharmacia Corporation |
Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2
|
|
JP4751063B2
(ja)
|
2002-05-17 |
2011-08-17 |
ファイザー イタリア ソシエタ ア レスポンサビリタ リミタータ |
キナーゼ阻害剤として活性のアミノインダゾール誘導体、それらの調製方法、及びそれらを含む薬学的組成物
|
|
CA2482838A1
(en)
|
2002-05-31 |
2003-12-11 |
Eisai Co., Ltd. |
Pyrazole compounds and pharmaceutical compositions containing the compound
|
|
US7196111B2
(en)
|
2002-06-04 |
2007-03-27 |
Schering Corporation |
Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
|
|
GB0218625D0
(en)
|
2002-08-10 |
2002-09-18 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
|
KR101312736B1
(ko)
|
2003-02-27 |
2013-09-27 |
팔라우 파르마 에스에이 |
피라졸로피리딘 유도체
|
|
GB0310867D0
(en)
*
|
2003-05-12 |
2003-06-18 |
Novartis Ag |
Organic compounds
|
|
PL2256106T3
(pl)
|
2003-07-22 |
2015-08-31 |
Astex Therapeutics Ltd |
Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
|
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
|
CN1829713A
(zh)
|
2003-07-30 |
2006-09-06 |
辉瑞大药厂 |
3,5二取代的吲唑化合物、药物组合物和介导或抑制细胞增殖的方法
|
|
WO2005014554A1
(en)
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
|
US8969372B2
(en)
|
2003-11-14 |
2015-03-03 |
Aptose Boisciences Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
|
FR2867778B1
(fr)
|
2004-03-16 |
2006-06-09 |
Sanofi Synthelabo |
Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
|
|
NZ550534A
(en)
|
2004-03-25 |
2009-07-31 |
Memory Pharm Corp |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
WO2006001894A1
(en)
|
2004-04-22 |
2006-01-05 |
Memory Pharmaceutical Corporation |
Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
|
|
EP1753428A4
(en)
|
2004-05-14 |
2010-09-15 |
Abbott Lab |
INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
|
|
MX2007001126A
(es)
|
2004-07-27 |
2007-09-25 |
Sgx Pharmaceuticals Inc |
Moduladores de heterociclo cinasa de anillo fusionado.
|
|
WO2006024945A1
(en)
|
2004-09-03 |
2006-03-09 |
Pfizer Inc. |
Pharmaceutical compositions comprising a cdk inhibitor
|
|
US20060116519A1
(en)
|
2004-11-17 |
2006-06-01 |
Agouron Pharmaceuticals, Inc. |
Synthesis of 5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
|
|
WO2006054143A1
(en)
|
2004-11-17 |
2006-05-26 |
Pfizer Inc. |
Polymorphs of {5-[3-(4,6-difluoro-1h-benzoimidazol-2-yl)-1h-indazol-5-yl]-4-methyl-pyridin-3-ylmethyl}-ethyl-amine
|
|
US20060127388A1
(en)
|
2004-12-10 |
2006-06-15 |
Wyeth |
Variants of glycogen synthase kinase 3 and uses thereof
|
|
US20060142247A1
(en)
|
2004-12-17 |
2006-06-29 |
Guy Georges |
Tricyclic heterocycles
|
|
US20060264897A1
(en)
|
2005-01-24 |
2006-11-23 |
Neurosystec Corporation |
Apparatus and method for delivering therapeutic and/or other agents to the inner ear and to other tissues
|
|
US7541367B2
(en)
|
2005-05-31 |
2009-06-02 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
TW200804338A
(en)
|
2005-11-24 |
2008-01-16 |
Astrazeneca Ab |
New compounds
|
|
EP1957109A2
(en)
|
2005-12-02 |
2008-08-20 |
Sirtris Pharmaceuticals, Inc. |
Modulators of cdc2-like kinases (clks) and methods of use thereof
|
|
MX2008011860A
(es)
|
2006-03-23 |
2008-09-30 |
Hoffmann La Roche |
Derivados de indazol substituidos, su manufactura y uso como agentes farmaceuticos.
|
|
JP5255559B2
(ja)
|
2006-03-31 |
2013-08-07 |
アボット・ラボラトリーズ |
インダゾール化合物
|
|
CA2651072A1
(en)
*
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
|
US20080153810A1
(en)
|
2006-11-15 |
2008-06-26 |
Forest Laboratories Holdings Limited |
Indazole derivatives useful as melanin concentrating receptor ligands
|
|
DE602006021591D1
(de)
|
2006-12-11 |
2011-06-09 |
Genetics Co Inc |
Aromatische 1,4-DI-Carboxylamide und deren Verwendung
|
|
EP1932830A1
(en)
|
2006-12-11 |
2008-06-18 |
The Genetics Company, Inc. |
Sulfonamides and their use as a medicament
|
|
ES2396160T3
(es)
|
2006-12-14 |
2013-02-19 |
Bayer Intellectual Property Gmbh |
Derivados de DIHIDROPIRIDINA que utiliza como inhibidores de la proteina quinasa
|
|
WO2008124848A1
(en)
|
2007-04-10 |
2008-10-16 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
WO2008137408A1
(en)
|
2007-04-30 |
2008-11-13 |
Genentech, Inc. |
Pyrazole inhibitors of wnt signaling
|
|
PT2152258T
(pt)
|
2007-05-10 |
2016-08-18 |
Avalon Pharmaceuticals |
Derivados de fluoreno, antraceno, xanteno, dibenzosuberona e acridina e suas utilizações
|
|
US8304408B2
(en)
|
2007-05-24 |
2012-11-06 |
The Regents Of The University Of California |
Wnt signaling inhibitors, and methods for making and using them
|
|
TW200908968A
(en)
|
2007-05-29 |
2009-03-01 |
Sgx Pharmaceuticals Inc |
Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
|
|
JP5451602B2
(ja)
|
2007-06-08 |
2014-03-26 |
アッヴィ・インコーポレイテッド |
キナーゼ阻害薬としての５−ヘテロアリール置換インダゾール類
|
|
EP2157859A4
(en)
|
2007-06-19 |
2011-01-12 |
Takeda Pharmaceutical |
INDAZOL COMPOUNDS FOR THE ACTIVATION OF GLUCCOKINASE
|
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
|
US20100190736A1
(en)
|
2007-08-02 |
2010-07-29 |
Nerviano Medical Sciences S.R.L. |
Morpholinyl anthracycline derivative combined with protein kinase inhibitors
|
|
KR20100044251A
(ko)
|
2007-08-15 |
2010-04-29 |
싸이토키네틱스, 인코포레이티드 |
특정 화학 물질, 조성물 및 방법
|
|
US9259399B2
(en)
|
2007-11-07 |
2016-02-16 |
Cornell University |
Targeting CDK4 and CDK6 in cancer therapy
|
|
WO2009085226A2
(en)
|
2007-12-21 |
2009-07-09 |
Sirtris Pharmaceuticals, Inc. |
Inhibitors of cdc2-like kinases (clks) and methods of use thereof
|
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
CN101440092B
(zh)
|
2008-12-25 |
2010-11-17 |
浙江大学 |
2-吲唑-4-氮杂吲哚-5-氨基衍生物及制备和应用
|
|
UA103918C2
(en)
|
2009-03-02 |
2013-12-10 |
Айерем Элелси |
N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
|
|
US20120022057A1
(en)
|
2009-03-18 |
2012-01-26 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacyglycerol acyltransferase
|
|
AU2010229144B2
(en)
|
2009-03-23 |
2012-07-12 |
Merck Sharp & Dohme Corp. |
P2X3, receptor antagonists for treatment of pain
|
|
JP2013500267A
(ja)
|
2009-07-23 |
2013-01-07 |
ヴァンダービルト ユニバーシティー |
ｍＧＬｕＲ４増強剤としての置換されたベンゾイミダゾールスルホンアミド類および置換されたインドールスルホンアミド類
|
|
JP2013501792A
(ja)
|
2009-08-10 |
2013-01-17 |
サミュメッド リミテッド ライアビリティ カンパニー |
Ｗｎｔ／ｂ−カテニンシグナル伝達経路阻害剤としてのインダゾールおよびその治療的使用
|
|
EP2987487B1
(en)
|
2009-08-10 |
2020-10-07 |
Samumed, LLC |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
|
US7998878B2
(en)
|
2009-11-20 |
2011-08-16 |
Eastman Kodak Company |
Method for selective deposition and devices
|
|
EP2515655B1
(en)
|
2009-12-21 |
2015-08-05 |
Samumed, LLC |
1h-pyrazolo[3,4-beta]pyridines and therapeutic uses thereof
|
|
CN102822170B
(zh)
|
2009-12-21 |
2014-12-10 |
阵列生物制药公司 |
作为cFMS抑制剂的取代的N-(1H-吲唑-4-基)咪唑并[1,2-a]吡啶-3-羧酰胺化合物
|
|
BR112012024705A2
(pt)
|
2010-03-31 |
2016-06-07 |
Actelion Pharmaceuticals Ltd |
derivados antibacterianos de isoquinolin-3-ilureia
|
|
CN102933557B
(zh)
|
2010-04-06 |
2016-08-03 |
彼得·麦卡勒姆癌症研究所 |
辐射防护剂化合物及方法
|
|
US20130310379A1
(en)
|
2010-11-19 |
2013-11-21 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
TW201307292A
(zh)
*
|
2010-12-17 |
2013-02-16 |
Hoffmann La Roche |
經取代之６，６－稠合含氮雜環化合物及其用途
|
|
CN102558173B
(zh)
*
|
2010-12-31 |
2015-05-20 |
广州源生医药科技有限公司 |
抑制wnt信号传导的化合物、组合物及其应用
|
|
US8889684B2
(en)
|
2011-02-02 |
2014-11-18 |
Boehringer Ingelheim International Gmbh |
Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
|
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
CN103889976A
(zh)
|
2011-08-12 |
2014-06-25 |
弗·哈夫曼-拉罗切有限公司 |
吲唑化合物、组合物及使用方法
|
|
EP3473099A1
(en)
*
|
2011-09-14 |
2019-04-24 |
Samumed, LLC |
Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
|
|
WO2013169793A2
(en)
*
|
2012-05-09 |
2013-11-14 |
Ipierian, Inc. |
Methods and compositions for tdp-43 proteinopathies
|
|
US9557993B2
(en)
|
2012-10-23 |
2017-01-31 |
Analog Devices Global |
Processor architecture and method for simplifying programming single instruction, multiple data within a register
|
|
WO2014110086A2
(en)
|
2013-01-08 |
2014-07-17 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
|
|
EP2945636B1
(en)
|
2013-01-16 |
2017-06-28 |
Signal Pharmaceuticals, LLC |
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
|
|
MX2016012208A
(es)
|
2014-03-20 |
2017-01-26 |
Samumed Llc |
Indazol-3-carboxamidas 5-substituidas y preparacion y uso de las mismas.
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
GB201416754D0
(en)
|
2014-09-23 |
2014-11-05 |
Mission Therapeutics Ltd |
Novel compounds
|
|
AR108325A1
(es)
*
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
AR108326A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
CN114149432B
(zh)
|
2016-09-30 |
2024-07-05 |
斯坦福国际研究院 |
用于癌症治疗的双重clk/cdk1抑制剂
|
|
WO2020006115A1
(en)
|
2018-06-26 |
2020-01-02 |
Betty Tam |
Methods of treating cancer using a clk inhibitor
|
|
WO2020150545A1
(en)
|
2019-01-17 |
2020-07-23 |
Samumed, Llc |
Pyrazole derivatives as modulators of the wnt/b-catenin signaling pathway
|